The proclamation states that more than 220,000 women and men are diagnosed with breast cancer each year, and 40,000 die as a result of the disease.
During the month of October, Brown's Car Stores and owner William E. Schuiling, will donate a portion of the proceeds from every vehicle sold to local Susan G. Komen affiliates and the Virginia Breast Cancer Foundation.
Male breast cancer is usually hereditary and if your family has history with the disease it could increase your risk.
Queensland Institute of Medical Research's Professor Chenevix-Trench told The New Daily it would help identify women at high risk who require earlier and more intensive screening.
Possessing a broken version of either of these genes is thought to account for as much as 10 percent of all breast cancers, and about 15 percent of ovarian cancers.
The total known number of mutations that can lead to breast cancer is now 180. A team at the Cleveland Clinic found differences in the types and amounts of bacteria between cancerous and non-cancerous breast tissue.
"These findings add significantly to our understanding of the inherited basis of breast cancer as well as identifying new genetic variants, we have also confirmed many that we had previously suspected", study investigator Doug Easton of the University of Cambridge said.
Significant changes in serum levels of estradiol and sex hormone-binding globulin and other yet unidentified mechanisms are responsible for the association between increased activity level and decreased risk for breast cancer.
Others, known as oestrogen-receptor negative, are not affected by the hormone and are more hard to treat.
"We knew about 100 before, it is a big contribution but probably more important than the number is the methods we developed", she said.
Yet breast cancer is still one of the most deadly forms of cancer for many women in the USA, coming second only to lung cancer for some demographic groups.
"But there are other risk factors".
The discovery of these 72 genetic variation also provides information for researchers " on the biology behind the development of cancer of the breast and on the different sub-types of breast cancer", which should enable it to find "new therapeutic targets", says Mr. Simard.
A further seven genes were identified specifically in association with breast cancers that lacked oestrogen receptors, which don't tend to respond to hormone based therapies.
Baroness Delyth Morgan, chief executive of the charity Breast Cancer Now, said: 'This is another exciting step forward in our understanding of the genetic causes of breast cancer.